If the Supreme Court strikes down Obamacare, these stocks would suffer.

Celgene Surges Higher Real Money Pro($)

CELG is far from overbought and will remain so for some time.
When a bearish investor of Klarman's stature goes long on a stock, pay attention.
That this could be such an open secret is beyond me.
Buy the breakout or within a narrow range at resistance.
Caution should trump fear of missing out on further gains.
Technical factors point to a looming breakout for IBB.
And UNH's buy signal is about to be renewed.
This could be an opportune price to buy REGN, as it allows you to take a position fairly close to well-defined support.
Take advantage of irrational collateral damage to stocks.

Columnist Conversations

So, why did the markets really get pasted on Monday? I believe it had more to do with the Greek politicians w...
Aetna (AET) is paying .8375 shares plus $125 cash for Humana (HUM). This along with Cigna (CI)-Anthem (ANTM) t...
"Ain't no time to hate, barely time to wait, Wo, oh, what I want to know, where does the time go?" Enjoy July ...


News Breaks

Powered by

Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.